Raised for research
Clinical trials
Drugs brought to market
Increase in life expectancy
Patients are at the center of everything we do. Every decision we make is grounded in the needs and best interests of the patients we serve.
We are committed to pursuing big, bold ideas. Taking risks, trying new approaches, and challenging the status quo are necessary to speed new discoveries.
Taking on complicated challenges is what sets us apart. To deliver results, we must be decisive, take action, and act with urgency on behalf of the myeloma community.
We know that together, we are stronger. We work cross-functionally with the entire community to achieve our mission and are invested in the success of others.
We build trust-based relationships. We advocate for each and every myeloma patient by committing to diversity, equity, and inclusion and treating others with respect.
Racial and ethnic biases, social and financial disparities, and lesser access to quality care are all contributing factors to the outcomes facing underserved populations. We believe research opportunities should be more equitable and remove barriers to treatment. Our goals focus on greater inclusivity in research to improve patient health outcomes.
Our executive team works tirelessly to drive new innovations forward that will improve the lives of multiple myeloma patients and bring us closer to a cure for every patient.
Our Board of Directors is comprised of industry leaders and investors who are deeply committed to curing cancer.
Our Scientific Advisory Board is a panel of international myeloma experts with broad expertise in oncology, translational research, and drug development.
